Collplant Biotechnologies Ltd Stock Ownership - Who owns Collplant Biotechnologies?


Insider buying vs selling

Have Collplant Biotechnologies Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

CLGN Shareholders

What type of owners hold Collplant Biotechnologies Ltd stock?
Roumell Asset Management LLC5.46%605,437$6.05MInstitution
Investment Management Of Virginia LLC3.13%346,533$3.46MInstitution
Villere St Denis J Co LLC2.41%266,897$2.67MInstitution
Ark Investment Management LLC2.13%235,660$2.35MInstitution
Brown Advisory Inc0.70%77,349$772.72kInstitution
Benjamin F Edwards Company Inc0.65%71,810$717.38kInstitution
Lpl Financial LLC0.41%45,070$450.25kInstitution
Zurcher Kantonalbank Zurich Cantonalbank0.21%23,210$231.87kInstitution
Parallel Advisors LLC0.15%16,382$163.66kInstitution
Simon Quick Advisors LLC0.14%15,676$156.60kInstitution

1 of 3

CLGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GNPX9.15%10.99%Net BuyingNet Buying
RZLT21.16%78.84%Net BuyingNet Buying
DBTX62.35%37.65%Net Selling

Collplant Biotechnologies Stock Ownership FAQ

Who owns Collplant Biotechnologies?

Collplant Biotechnologies (NASDAQ: CLGN) is owned by 15.67% institutional shareholders, 0.00% Collplant Biotechnologies insiders, and 84.33% retail investors. Roumell Asset Management LLC is the largest individual Collplant Biotechnologies shareholder, owning 605,437.00 shares representing 5.46% of the company. Roumell Asset Management LLC's Collplant Biotechnologies shares are currently valued at $5.79M.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.